Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Gene Therapy
Findings in gene therapy reported from University of Georgia, Research Center
August 6th, 2008
Fresh data on gene therapy are presented in the report 'Protection against infectious bursal disease virulent challenge conferred by a recombinant avian adeno-associated virus vaccine.' According to recent research from the United States, "The development and use of recombinant vaccine vectors for the expression of poultry pathogens proteins is an active research field. The adeno-associated virus (AAV) is a replication-defective virus member of the family Parvoviridae that has been successfully used for gene delivery in humans and other species." "In this experiment, an avian adeno-associated virus (AAAV) expressing the infectious bursal disease virus (IBDV) VP2 protein...
Source: Vaccine Weekly (2008-08-06)
|
